Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 3,717 | 3,662 | 5,940 | 3,709 | 3,294 |
| Operating Income | -3,717 | -3,662 | -5,940 | -3,709 | -3,294 |
| Other Income | 44 | 38 | 36 | 72 | 54 |
| Pre-tax Income | -3,673 | -3,624 | -5,904 | -3,637 | -3,240 |
| Net Income Continuous | -3,673 | -3,624 | -5,904 | -3,637 | -3,240 |
| Net Income | $-3,673 | $-3,624 | $-5,904 | $-3,637 | $-3,240 |
| EPS Basic Total Ops | -9.07 | -10.08 | -17.60 | 26.91 | -14.20 |
| EPS Basic Continuous Ops | -9.07 | -10.08 | -17.57 | 27.07 | -14.29 |
| EPS Diluted Total Ops | -9.07 | -10.08 | -17.60 | 26.91 | -14.20 |
| EPS Diluted Continuous Ops | -9.07 | -10.08 | -17.57 | 27.07 | -14.29 |
| EBITDA(a) | $-3,655 | $-3,597 | $-5,875 | $-3,647 | $-3,228 |